Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine

  • Hua Shen
    Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China
  • Xiaoyi Huang
    Department of Pathology, Changhai Hospital, Second Military Medical University, Changhai Road 168#, Shanghai 200433, China
  • Jie Min
    Department of Cardiothoracic Surgery, Bethune International Peace Hospital, Shijiazhuang, China
  • Shiguan Le
    Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China
  • Qing Wang
    Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China
  • Xi Wang
    Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China
  • Asli Aybike Dogan
    Department of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, 35100 Bornova-Izmir, Turkey
  • Xiangsheng Liu
    California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
  • Pengfei Zhang
    Department of Central Laboratory, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China
  • Mohamed S. Draz
    Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, United States
  • Jian Xiao
    Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China

説明

<jats:sec> <jats:title /> <jats:p>The rapid development of nanotechnology has a great influence on the fields of biology, physiology, and medicine. Over recent years, nanoparticles have been widely presented as nanocarriers to help the delivery of gene, drugs, and other therapeutic agents with cellular targeting ability. Advances in the understanding of gene delivery and RNA interference (RNAi)-based therapy have brought increasing attention to understanding and tackling complex genetically related diseases, such as cancer, cardiovascular and pulmonary diseases, autoimmune diseases and infections. The combination of nanocarriers and DNA/RNA delivery may potentially improve their safety and therapeutic efficacy. However, there still exist many challenges before this approach can be practiced in the clinic. In this review, we provide a comprehensive summary on the types of nanoparticle systems used as nanocarriers, highlight the current use of nanocarriers in recombinant DNA and RNAi molecules delivery, and the current landscape of gene-based nanomedicine-ranging from diagnosis to therapeutics. Finally, we briefly discuss the biosafety concerns and limitations in the preclinical and clinical development of nanoparticle gene systems.</jats:p> </jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ